Top

Phyu P Aung, M.D., Ph.D., F.CAP., F.ASCP

Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div

About Dr. Aung

I am a Professor of Pathology and a practicing Dermatopathologist with over 10 years of experience. My expertise as diagnostician for cutaneous tumors is nationally recognized; therefore, my opinion is often requested in challenging cases. I am also Director of Surgical Pathology Fellowship Program in our department which is the largest ACGME-accredited Fellowship Program in our institution since 2019. Prior to assuming the directorship position, I served as co-director of the fellowship. In addition, I am currently Site Director of Pathology fellowship Programs, and oversees the educational activities of rotating residents, fellows and observers (more than 40 trainees/year) in our department.

My research interest includes rare cutaneous neoplasms including acral melanoma, merkel cell carcinoma (MCC), blastic plasmacytoid dendritic cell neoplasm (BPDCN) and extramammary Paget disease, molecular advancement of diagnostic pathology and digital pathology. Our department is heavily focused on diagnostic responsibilities, and independent grant funding for early career faculty is unusual. However, with 13% of my effort dedicated to research, I have excelled in securing twelve intra- and extramural grant funding as Principal Investigator which include the Melanoma Research Alliance (MRA) covering 10% FTE. My work in cancer biology and cutaneous lesions has resulted in over 200 refereed journal publications (78 of these as first/corresponding author), 12 book chapters and over 200 poster/platform presentations at national and international conferences with a Google Scholar h index of 38. My work has been published in high-impact journals, including JAMA Oncology, Nature Communications, Modern Pathology, and Clinical Cancer Research. I am also a grant reviewer of 4 national and international societies including NIH. I serve on the editorial board and guest editor of the Journals, lead editor for Virtual Biopsy Program (VBP) from CAP, editor for Performance Improvement Program in Surgical Pathology (PIP) as well as Digital Slide Program-Dermatopathology (DPATH) from CAP and ad hoc reviewer for more than 30 journals. For all of my research accomplishment despite an 75% clinical load on the very busy Dermatopathology service, I was recognized with the Shirley Stein Scientific Endowed Research Award (which recognizes exceptional clinical research by faculty members with limited project resources) in 2020 and Early Career Faculty Research Award, Division of Pathology and Laboratory Medicine, at UT- MD Anderson Cancer Center, 2021, and American Society of Clinical Pathology (ASCP) Philip Levine Award for Outstanding Research, 2022.

With 12% of my effort dedicated to education, mentoring and administration, I have been serving as a member of Committee/Executive Committee of multiple national and international Pathology and Dermatopathology Societies including International Society of Dermatopathology (ISDP), College of American Pathology (CAP), American Society of Dermatopathology (ASDP), United States & Canadian Academy of Pathology (USCAP), Asian Society of Dermatopathology (ASD-cofounder). In addition, I have managed to carve out a national and international presence in the area of cutaneous malignancies, specifically melanoma and other rare cutaneous neoplasms by being invited to present and chair over 70 courses and seminars at national and international meetings and academic institutions in more than 30 different countries. I considered myself a very passionate teacher and has mentored >100 national and international residents, fellows and practicing physicians. I have authored 75 peer-reviewed publications and 113 abstracts with a fellow or resident as 1st author and received 8 fellow-mentor grants with my mentees. I have also mentored fellows/residents who are recipients of the Physician-in-Training Award for Best Presentation at the ASDP meetings in 2018 and 2020, the Best Oral Presentation at the 94th Annual Meeting of the Texas Society of Pathologists (TSP) in 2015 and the special Dr. Juan Rosai Award from the Latin American Pathology Foundation at the annual United States & Canadian Academy of Pathology (USCAP) in 2021. In recognition of my commitment to education and mentorship, I received the Faculty Educator Award (2021); Outstanding Faculty Mentor Award from the Interdisciplinary Translational Education and Research Training Program (2021); Faculty Excellence Award for Mentorship in Surgical Pathology (2022); Multi Year Appointment Award for Clinical Faculty (2022); UT System Regents’ Outstanding Teaching Award (2022); Arthur Purdy Stout Society Annual Prize (2022); Clinical Education Emil J. Freireich Award for Excellence in Education, GME (2023); Faculty Scholar award (2023); Distinguished Faculty Mentor Award (Clinical); Academic Mentoring Council (2023); and 2023 Academy Inductee, MD Anderson Academy of Health Science Education, MD Anderson's "Hall of Fame" for educators.

I also serve to our institution in the leadership roles; as Chair of Mid-Career Faculty Committee (MCFC) representing ~650 associate professors at MDACC, member of Academic Leadership Team (ALT) senator of faculty senate, voting member of graduate medical education committee and member of functional mentoring program.

I have excelled as a leader in all three classical spheres of academia: patient care, research, and education, as evidenced in my curriculum vitae. For all my above-mentioned accomplishments, I received early promotion to Associate Professor rank in 2019 and to Professor rank in 2014, President's Recognition of Faculty Excellence Award in 2020 and Arthur Purdy Stout Society Annual Prize from the United States and Canadian Academy of Pathology (USCAP) in 2022. More recently I received 2024 Lifetime Achievement Award from CAP recognizing not only my precise diagnoses having positively impacted patients but also my mentorship has shaped the careers of countless pathology trainees who now hold positions in esteemed institutions nationwide.

Primary Appointment

Professor, Department of Pathology, Division of Pathology-Lab Medicine Div, The University of Texas MD Anderson Cancer Center, Houston, TX

Director, Surgical Pathology Fellowship Program (with 14 fellows per year), Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Education & Training

Degree-Granting Education

2006	Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, JP, Ph.D. in Molecular Pathology
2002	Bachelor of Medicine and Bachelor of Surgery, Institute of Medicine 1, Yangon (Rangoon), MM, MBBS in Medicine (MDA equivalent)

Postgraduate Training

2023-2024	CoachRICE(International Federation of Coach Certified), in partnership with Rice University’s The Doerr Institute for New Leaders, Houston, Texas
2023-2024	The APC Pathology Leadership Fellows (APLF) program, Leadership skills, The Association of Pathology Chairs (APC), Wilmington, Delaware
2023-2023	Physician Well-being Director Course, Stanford Medicine WellMD & WellPhD, Stanford, California
2023-2023	Emotional Intelligence Certificate program, Case Western Reserve Univ. Weatherhead School of Management and MD Anderson Leadership Institute, Houston, Texas
2022-2023	Apprenticeship, Improving Data Literacy, Faculty Academic Career Development Program, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2022-2023	Graduate of LEADing Others Accelerate Leadership Program, sponsored by MD Anderson's Leadership Institute, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2022-2022	Advanced Six Sigma Yellow Belt Certification Quality Improvement Program, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2022-2023	Inaugural Faculty Academic Career Development (FACD) Academy, Administrative leadership skills, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2022-2022	Leader Skills and Universal Skills for LEADing Others and Above - High Reliability, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2021-2021	Engaged Leadership Academy, College of American Pathology (CAP), Chicago, Illinois
2021-2021	The 3rd Annual Women's Sponsorship Workshop. Mentor-Protege' Program. The Faculty Leadership Academy, The University of Texas MD Anderson Cancer Center, Houston, Texas
2021-2022	Community of Medical Education Scholars (CoMES) Program, The University of Texas Health Science Center at Houston and McGovern Medical School, Houston, Texas
2021-2021	LEAD Oral Communication: Presentation Skills for Leaders. Leadership Institute, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2021-2021	Courses for Career Development of Educators in Healthcare in Education Week, The University of MD Anderson Cancer Center, Houston, Texas
2021-2021	The Mentoring Program, The Faculty Leadership Academy, The University of MD Anderson Cancer Center, Houston, Texas
2021-2021	Graduate of LEADing Others Leadership Program, The Faculty Leadership Academy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2021-2021	LEADing at MD Anderson, the Leadership Institute, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2021-2021	LEADing with Emotional Intelligence, the Leadership Institute, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2021-2022	The Mentorship Program, The American Society for Clinical Pathology (ASCP), Chicago, Illinois
2020-2020	The Mentor Training Workshop for faculty, Gulf Coast Consortia for Quantitative Biosciences, The University of Texas MD Anderson Cancer Center, Houston, Texas
2020-2020	Engaged Leadership Academy, College of American Pathology (CAP), Chicago, Illinois
2020-2020	The 2nd Annual Women's Sponsorship Workshop. Mentor-Protege' Program. The Faculty Leadership Academy, The University of Texas MD Anderson Cancer Center, Houston, Texas
2020-2020	Financial Bootcamp for Understanding of Health Care Industry Finances, The Faculty Leadership Academy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2019-2019	Early Career Women Faculty Leadership Development Seminar, The Association of American Medical Colleges (AAMC), St. Louis, Missouri
2019-2021	The Mentoring Academy, United States & Canadian Academy of Pathology (USCAP), Palm Springs, California
2017-2018	Heart of Leadership of the Faculty Leadership Academy, The University of Texas MD Anderson Cancer Center, Houston, Texas
2016-2017	Faculty Supervisory & Management Program of the Faculty Leadership Academy, The University of Texas MD Anderson Cancer Center, Houston, Texas
2012-2014	Clinical Fellowship, Department of Dermatopathology, Boston University School of Medicine, Boston, Massachusetts
2011-2012	Chief Resident, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
2009-2012	Clinical Residency, Anatomic Pathology/Laboratory of Pathology, National Institutes of Health, Bethesda, Maryland
2008-2009	Post-doctoral Fellow, Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio
2006-2008	Post-doctoral Fellow, Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio
2003-2006	Graduate Student, Department of Molecular Pathology, Graduate School of Biomedical Sciences and School of Medicine, Hiroshima University, Hiroshima
2002-2003	Clinical Internship, Rangoon General Hospital, Rangoon Children's Hospital and Rangoon Central Women's Hospital, Rangoon

Board Certifications

2012	Anatomic Pathology by American Board of Pathology-Lifetime

Experience & Service

Academic Appointments

Associate Professor, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2019 - 2024

Assistant Professor, Department of Pathology, Division of Pathology/La Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2014 - 2019

Administrative Appointments/Responsibilities

Chair, Mid-Career Faculty Committee (MCFC), Department of Faculty Academic Affairs, Chief Academic Officer Office, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - 2024

Chair of The Stephen Vogel Award Committee, United States and Canadian Academy of Pathology (USCAP), Houston, Texas, 2022 - Present

Secretary-General (President Elect), Asian Society of Dermatopathology (ASD), Houston, Texas, 2022 - Present

Director, Surgical Pathology Fellowship Program, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2019 - Present

Site Director of Rotating Physicians, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present

Institutional Committee Activities

Member, Designed Institutional Committee, 2024 - Present

Past-Chair, Mid-Career Faculty Committee (MCFC), 2023 - 2024

Executive Committee Member, Data Governance Executive Committee, 2023 - Present

Member, Institutional Review Subcommittee, Graduate Medical Education, 2023 - Present

Chair, Mid-Career Faculty Committee (MCFC), 2022 - 2023

Team Member, Academic Leadership Team (ALT) led by Chief Academic Officer, 2022 - Present

Member, The Faculty Academic Career Development Academy, The University of Texas MD Anderson Cancer Center, 2022 - Present

Chair elect, Institutional Committee, 2021 - 2022

Senator, Faculty Senate, 2021 - Present

Committee Member, Functional Mentoring Program, 2021 - Present

Member, Education Committee, Faculty Senate, 2021 - Present

Mentor, The Mentoring Program, The Faculty Leadership Academy, 2021 - Present

Member, Mid-Career Faculty Committee (MCFC), The University of Texas MD Anderson Cancer Center, 2020 - 2024

Member, Early Career Faculty Divisional Committee, Division of Pathology/Lab Medicine, 2020 - 2022

Voting Member, Graduate Medical Education Committee, 2019 - Present

Organizer, Journal Club for Surgical/Cytopathology Fellows in Department of Pathology, 2017 - 2020

Chair-Elect Finalist and Departmental Representative, Focus on Junior Faculty (FJF) Committee, 2016 - 2020

Member, MDACC Oncologic Surgical Pathology General and Subspecialty Fellowships – Lecture Critique and Award Committee, 2016 - Present

Chair, Program Evaluation Committee (PEC) for Dermatopathology Fellowship, 2015 - 2016

Member, Clinical Competency Committee (CCC) and Program Evaluation Committee (PEC) for Dermatopathology Fellowship, 2014 - Present

Honors & Awards

	Japanese Government Scholar Award
	Best Poster Award, Hiroshima Cancer Seminar Foundation, Japan
	Best Graduate Student Award by Dean of Hiroshima University, Hiroshima University, Japan
	Scholar-in-training Award, American Association for Cancer Research (AACR)
	Best Presentation Award, Japanese Association for Metastasis Research
	Best Poster of the Session Prize, International Gastric Cancer Association
	Teacher Award, Hiroshima University School of Medicine
	Arthur Purdy Stout Society (APSS) of Surgical Pathologists Study Stipend
	First prize of Papanicolaou Society of Cytopathology (PSC) resident research award
	Institutional Research Funding Award, The University of Texas MD Anderson Cancer Center
	Mentor of the recipient of the Award for the Best Oral Presentation (Dr. Laurence Feldmeyer), The 94th Annual Meeting of the Texas Society of Pathologists (TSP)
	Mentor of the recipient of the Physician-in-Training Award for Best Poster Presentation (Dr Maya Farah), Annual Meeting of American Society of Dermatopathology (ASDP)
	Mentored Fellow Research Grant (Dr. Dinesh Pradhan) (Competitively selected by the review committee), Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center
	Department Chair Funds for Mentored Trainee Research (Dr. Nisha Ramani) (Competitively selected by the review committee), Department of Pathology, The University of Texas MD Anderson Cancer Center
	Representative to the Association of American Medical Colleges (AAMC) Early Career Women Faculty Leadership Development Seminar, competitively selected by AAMC Application Selection Committee
	Mentored Fellow Research Grant (Dr. Michael Zaleski) (Competitively selected by the review committee), Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center
	Department Chair Funds for Mentored Trainee Research (Dr. Woo Cheal Cho), Department of Pathology (Competitively selected by the review committee), The University of Texas MD Anderson Cancer Center
	Young Investigator Award (YIA), Melanoma Research Alliance (MRA)
	Institutional Research Grant (IRG) Award, The University of Texas MD Anderson Cancer Center
	The 2nd Annual Women's Sponsorship Workshop. Mentor-Protege' Program The Faculty Leadership Academy, The University of Texas MD Anderson Cancer Center. Women Leadership Network (WLN) Application Selection Committee
	Mentor of the recipient of the Physician-In-Training Award for Best Poster Presentation (Dr. Michael Occidental), Annual Meeting of American Society of Dermatopathology (ASDP)
	Mentor of the recipient of the Physician-In-Training Award for Best Platform Presentation (Dr. Katrina Collins), Annual Meeting of American Society of Dermatopathology (ASDP)
	Finalist of Early Career Faculty for Outstanding Achievement Award, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center
	Mentored Fellow Research Grant (Dr. Woo Cheal Cho) (Competitively selected by the review committee), Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center
	President's Recognition of Faculty Excellence Award, The University of Texas MD Anderson Cancer Center
	The Shirley Stein Endowment Research Award
	The 3rd Annual Women's Sponsorship Workshop. Mentor-Protege' Program. The Faculty Leadership Academy, The University of Texas MD Anderson Cancer Center. Women Leadership Network (WLN) Application Selection Committee
	Engaged Leadership Academy (ELA), Competitively Awarded by College of American Pathology (CAP) ELA Application Selection Committee
	Mentored Fellow Research Grant (Dr. Kaitlin Vanderbeck) (Competitively selected by the review committee), Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center
	Faculty Educator of the quarter for the first quarter, Department of Education & Training, The University of Texas MD Anderson Cancer Center
	Early Career Faculty Research Award, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center
	Department Chair Funds for Mentored Trainee Research (Dr. Kaitlin Vanderbeck), Department of Pathology (Competitively selected by the review committee), The University of Texas MD Anderson Cancer Center
	Mentor of the recipient of the special Dr. Juan Rosai Award from the Latin American Pathology Foundation (Dr. Rossana Lazcano), Annual Meeting of the United States & Canadian Academy of Pathology (USCAP)
	The American Society of Clinical Pathology (ASCP) Philip Levine Award for Outstanding Research, The American Society of Clinical Pathology (ASCP)
	Outstanding Faculty Mentor Award. Interdisciplinary Translational Education and Research Training (ITERT), The University of Texas MD Anderson Cancer Center
	Multi Year Appointment Award for Clinical Faculty, The University of Texas MD Anderson Cancer Center
	Mentor of the recipient of the Best Poster Presentation (Dr. Kaitlin Vanderbeck), The 2nd Annual Research Symposium, Division of Pathology and Laboratory Medicine (DPLM)
	Finalist, Faculty Educator of the Year, Department of Education & Training, The University of Texas MD Anderson Cancer Center
	Arthur Purdy Stout Society (APSS) Annual Prize to Recognize Significant Career Achievements in Surgical Pathology, USCAP-APSS Companion Society
	Mentor Fellow Research Grant (Dr. Yi A. Liu) (Competitively selected by the review committee) Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center
	UT System Regents’ Outstanding Teaching Award, The University of Texas System
	Faculty Excellence Award for Mentorship, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center
	2023 Academy Inductee, MD Anderson Academy of Health Science Education, MD Anderson’s “Hall of Fame” for educators
	UT-MD Anderson Mentoring Champion representing Division of Pathology and Lab Medicine
	Multi Year Appointment Award for Clinical Faculty (For outstanding clinical performance, excellence in research support, significant educational contributions, exemplary institutional service at MDACC, recognition as established in my field and administrative leadership in a prominent service role), The University of Texas MD Anderson Cancer Center
	Distinguished Faculty Mentor Award (Clinical), Academic Mentoring Council, The University of Texas MD Anderson Cancer Center
	Department Chair Funds for Mentored Trainee Research (Dr. Feifan Chen), Department of Pathology (Competitively selected by the review committee), The University of Texas MD Anderson Cancer Center
	Clinical Education Emil J. Freireich Award for Excellence in Education, Graduate Medical Education, The University of Texas MD Anderson Cancer Center
	Lifetime Achievement Award, The College of American Pathologists (CAP) (for my renowned support of early-career pathologists)
	Faculty Scholar Award (President's Recognition of Faculty Excellence) 2023-2026, The University of Texas MD Anderson Cancer Center

Professional Memberships

Asian Society of Dermatopathology

President, 2025 - 2027

The Association of Directors of Anatomic and Surgical Pathology

Member, 2024 - Present

American Society of Clinical Oncology

Member, 2024 - Present

United States and Canadian Academy of Pathology

Member of Education Committee (representing the Dermatopathology Subspecialty), 2023 - Present

United States and Canadian Academy of Pathology

Chair of The Stephen Vogel Award Committee, 2022 - Present

Asian Society of Dermatopathology

Secretary-General (President Elect), 2022 - 2024

The Stephen Vogel Award Committee United States and Canadian Academy of Pathology

Chair, 2022 - Present

Arthur Purdy Stout Society of Surgical Pathologists

Member, 2022 - Present

College of American Pathologists

Member of House of Delegates, Texas Delegation, 2021 - Present

College of American Pathologists

Member of Artificial Intelligence (AI) Committee, AI Products Work Group, 2021 - Present

American Society of Dermatopathology

Member of Membership Committee, 2021 - Present

American Society of Clinical Pathology

Mentor of The Mentoring Program, 2021 - Present

College of American Pathologists

Member of Digital Pathology Committee, Telepathology/Whole Slide Imaging/Digital Image Analysis Work Group, 2021 - Present

College of American Pathologists

Member of Dermatopathology Committee, 2020 - Present

Association of Pathology Informatics

Member, 2020 - Present

American Society of Clinical Pathology

Residency Program's Pathology Ambassador, 2020 - Present

International Society of Dermatopathology

Executive Committee Member, 2019 - Present

United States and Canadian Academy of Pathology

Mentor of Mentoring Academy, 2019 - Present

Asian Society of Dermatopathology

Executive Committee Member, 2019 - 2022

Asian Society of Dermatopathology

Member of Membership committee, 2019 - Present

College of American Pathologists

Member of Surgical Pathology Committee, 2018 - Present

Asian Society of Dermatopathology

Co-Founder, 2017 - Present

Houston Society of Clinical Pathologists

Chair of Membership Committee, 2017 - 2019

College of American Pathologists

Member, 2016 - Present

College of American Pathologists

Inspection Team Leader, 2016 - Present

American Society of Dermatopathology

Member of VSL (Virtual Slide Library) Committee, 2016 - Present

Harris County Medical Society

Member, 2016 - Present

Houston Society of Clinical Pathologists

Member, 2014 - Present

Texas Society of Pathologists

Member, 2014 - Present

International Society of Dermatopathology

Member, 2012 - Present

American Society of Dermatopathology

Member, 2010 - Present

American Society of Clinical Pathology

Member, 2009 - Present

United States and Canadian Academy of Pathology

Member, 2009 - Present

Japanese Cancer Association (JCA)

Member, 2003 - 2006

American Association of Cancer Research

Member, 2003 - 2008

Japanese Society of Pathology

Member, 2003 - 2006

Selected Publications

Peer-Reviewed Articles

Pineda-Reyes J, Arudra SK, Aung PP, Nagarajan P, Curry JL, Tetzlaff M, Prieto VG, Wang WL, Hwu WJ, Torres-Cabala CA. Dual PD-L1/SOX10 Immunohistochemistry Combined With Digital Imaging Enhances Stratification Accuracy of Patients With Metastatic Melanoma. Am J Surg Pathol None(None):None, 2024. PMID: 39373029.
Ozkizilkaya HI, Vinocha A, Dono A, Ogunbona OB, Toruner GA, Aung PP, Kamiya Matsuoka C, Esquenazi Y, DeMonte F, Ballester LY. MTAP and p16 IHC as Markers for CDKN2A/B Loss in Meningiomas. Cancers (Basel) 16(19):None, 2024. PMID: 39409918.
Zvulunov A, Neale H, Stern J, Santaguida P, Stein AB, Koh M, Eichenfield LF, Guitart J, Goebeler M, Scarisbrick J, Willemze R, Coughlin CC, George R, Brazzelli V, Marschalko M, Belousova I, Querfeld C, Bagot M, Szepietowski JC, Papadavid E, Quaglino P, Hoeger P, Ortiz-Romero PL, Nikolaou V, Dummer R, Aung PP, Lawley L, Morel KD, Ngan B, Wain M, Gameiro A, Lacy-Niebla RM, Pope E. Approach to Mycosis Fungoides in children: Consensus-based recommendations. J Am Acad Dermatol None(None):None, 2024. PMID: 39181404.
Kwon D, Taherian M, Milton DR, Iaeger P, Chin K, Aung PP. The Secret Life of Junior Pathologists: Challenges and Future Directions. Arch Pathol Lab Med 148(7):836-845, 2024. PMID: 37852170.
Ledesma DA, Marques-Piubelli ML, Li-Ning-Tapia E, Hudgens C, Gu J, Lazcano R, Casavilca-Zambrano S, Castillo M, Davies MA, Hwu WJ, Aung PP, Giubellino A, Curry JL, Torres-Cabala C. Apoptosis Pathway-Associated Proteins Are Frequently Expressed in Melanoma: A Study of 32 Cases With Focus on Acral Lentiginous Melanoma. Am J Dermatopathol 46(7):410-415, 2024. PMID: 38718197.
Chen F, Nagarajan P, Aung PP. Digital Papillary Adenocarcinoma: The Detection of Low-Risk Human Papillomaviruses and the BRAF p.V600E Mutation in a Subset of Cases. Dermatopathology (Basel) 11(3):177-183, 2024. PMID: 39051320.
Shehabeldin A, Rohra P, Sellen LD, Zhao J, Alqaidy D, Aramin H, Hameed N, Perez YE, Lai Z, Tong YT, Milton DR, Edgerton ME, Fuller G, Hansel D, Prieto VG, Ballester LY, Aung PP. Utility of Whole Slide Imaging for Intraoperative Consultation: Experience of a Large Academic Center. Arch Pathol Lab Med 148(6):715-721, 2024. PMID: 37756559.
Ramos, J, Aung, PP. International Medical Graduates and the Shortage of US Pathologists. Archives of pathology & laboratory medicine 148(6):735-738, 2024. PMID: 37787415.
Turcios Escobar, S, Yang, RK, Nelson, KC, Gershenwald, JE, Tawbi, H, Aung, PP, Patel, SP, Torres Cabala, CA. Utility of next-generation sequencing in the diagnosis of metastatic melanoma. Journal of cutaneous pathology 51(9):644-648, 2024. PMID: 38757469.
Dimopoulos YP, Kwon D, Milton DR, Iaeger PI, Hansel DE, Prieto VG, Chin KE, Aung PP. Assessing the Impact of the COVID-19 Pandemic on Training at the MD Anderson Cancer Center Anatomical Pathology Fellowship Program. Arch Pathol Lab Med 148(5):559-565, 2024. e-Pub 2023. PMID: 37639451.
Cho WC, Saade R, Nagarajan P, Aung PP, Milton DR, Marques-Piubelli ML, Hudgens C, Ledesma D, Nelson K, Ivan D, Zhang M, Torres-Cabala CA, Campbell M, Alhalabi O, Prieto VG, Wistuba II, Esmaeli B, Curry JL. Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotin. J Cutan Pathol 51(5):360-367, 2024. PMID: 38200650.
Salem, A, Wu, Y, Albarracin, C, Middleton, LP, Kalhor, N, Peng, Y, Huang, X, Aung, PP, Chen, H, Sahin, AA, Ding, Q. A Comparative Evaluation of TRPS1 and GATA3 in adenoid cystic, secretory, and acinic cell carcinomas of the breast and salivary gland. Human Pathology 145:42-47, 2024. PMID: 38262580.
Marques-Piubelli, ML, Navarrete, J, Ledesma, D, Hudgens, CW, Segura Lazcano, R, Alani, A, Huen, A, Duvic, M, Nagarajan, P, Aung, PP, Wistuba, II, Curry, JL, Miranda, RN, Torres Cabala, CA. Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides. Cells 13(5), 2024. PMID: 38474383.
Liu YA, Aung PP, Wang Y, Ning J, Nagarajan P, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Ding Q, Cho WC. TRPS1 expression in non-melanocytic cutaneous neoplasms: an immunohistochemical analysis of 200 cases. J Pathol Transl Med 58(2):72-80, 2024. PMID: 38389280.
Wang J, Peng Y, Sun H, Aung PP, Resetkova E, Yam C, Sahin AA, Huo L, Ding Q. TRPS1 and GATA3 Expression in Invasive Breast Carcinoma With Apocrine Differentiation. Arch Pathol Lab Med 148(2):200-205, 2024. PMID: 37074839.
Liu YA, Collins K, Aung PP, Nagarajan P, Curry JL, Prieto VG, Torres-Cabala CA, Cho WC. TRPS1 expression in primary and secondary extramammary Paget diseases: An immunohistochemical analysis of 93 cases. Hum Pathol 143:5-9, 2024. PMID: 38000676.
Ronen S, McAfee JL, Curry JL, Nagarajan P, Aung PP, Ivan D, Prieto VG, Tetzlaff MT, Torres-Cabala C. Phenotypic switch in mycosis fungoides: A tertiary cancer center experience. Hum Pathol 142:27-33, 2023. PMID: 37977511.
Cass S, Cope B, Bishop AJ, Chiang YJ, Ashleigh Guadagnolo B, Farooqi A, Morrison W, Witt RG, Seervai RNH, Garden AS, Fuller CD, Goepfert RP, Ross M, Gershenwald JE, Wong M, Aung PP, Keung EZ, Mitra D. Primary tumor site for localized Merkel cell carcinoma drives different management strategies without impacting oncologic outcomes. Radiother Oncol 188:109892, 2023. e-Pub 2023. PMID: 37659660.
Small C, Mukerjee S, Jangam D, Gollapudi S, Singh K, Jaye DL, Aung PP, Querfeld C, Yao K, Chisholm KM, Pullarkat S, Wang S, Gru A, Hussaini M, George TI, Ohgami RS. Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms. Int J Lab Hematol 45(5):726-734, 2023. PMID: 37282364.
Hoffman-Hall A, Puett R, Silva JA, Chen D, Bredder A, Shevade V, Han ZY, Han KT, Aung PP, Plowe CV, Nyunt MM, Loboda TV. Comparison of deforestation and forest land use factors for malaria elimination in Myanmar. IJID Reg 8(None):75-83, 2023. PMID: 37533552.
Cho WC, Li W, Gu J, Wang WL, Ning J, Sfamenos S, Gill P, Nagarajan P, Curry JL, Lazar AJ, Prieto VG, Torres-Cabala CA, Aung PP. Telomerase reverse transcriptase immunohistochemical expression is sensitive but not specific for TERT gene amplification in acral melanoma. J Cutan Pathol 50(9):845-851, 2023. e-Pub 2023. PMID: 37400233.
Vanderbeck K, Rothrock AT, Cho WC, Nagarajan P, Aung PP, Hudgens C, Bassett RL, Ivan D, Prieto VG, Curry JL, Torres-Cabala CA. PRAME and LEF1 in Combined Deep Penetrating Nevus and Combined Blue Nevus: Utility and Pitfalls. Am J Dermatopathol 45(8):549-556, 2023. PMID: 37462205.
Cho WC, Vanderbeck K, Nagarajan P, Milton DR, Gill P, Wang WL, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Aung PP. SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma. Arch Pathol Lab Med 147(7):758-766, 2023. e-Pub 2023. PMID: 36745184.
Ohgami RS, Aung PP, Gru AA, Hussaini M, Singh K, Querfeld C, Yao K, Small C, Gollapudi S, Jaye D, Wang SA, Pullarkat S, George TI. An Analysis of the Pathologic Features of Blastic Plasmacytoid Dendritic Cell Neoplasm Based on a Comprehensive Literature Database of Cases. Arch Pathol Lab Med 147(7):837-846, 2023. e-Pub 2022. PMID: 36170615.
Marques-Piubelli ML, Seervai RNH, Mudaliar KM, Ma W, Milton DR, Wang J, Muhlbauer A, Parra ER, Solis LM, Nagarajan P, Speiser J, Hudgens C, Cho WC, Aung PP, Patel A, Pacha O, Nelson KC, Tetzlaff MT, Amaria RN, Torres-Cabala CA, Prieto VG, Wistuba II, Curry JL. Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of T(H) 1 T-cells. J Cutan Pathol 50(7):661-673, 2023. e-Pub 2023. PMID: 37150813.
Loo LWJ, Chew QH, Lin SK, Yang SY, Ouyang WC, Chen CK, Park SC, Jang OJ, Park JH, Chee KY, Ding KS, Chong J, Zhang L, Li K, Zhu X, Jatchavala C, Pariwatcharakul P, Kallivayalil RA, Grover S, Avasthi A, Ansari M, Maramis MM, Aung PP, Sartorius N, Xiang YT, Tan CH, Chong MY, Park YC, Kato TA, Shinfuku N, Baldessarini RJ, Sim K. Clozapine Use for Bipolar Disorder: An Asian Psychotropic Prescription Patterns Consortium Study. J Clin Psychopharmacol 43(3):278-282, 2023. PMID: 37068038.
Cho WC, Ding Q, Wang WL, Nagarajan P, Curry JL, Torres-Cabala CA, Ivan D, Albarracin CT, Sahin A, Prieto VG, Aung PP. Immunohistochemical expression of TRPS1 in mammary Paget disease, extramammary Paget disease, and their close histopathologic mimics. J Cutan Pathol 50(5):434-440, 2023. e-Pub 2023. PMID: 36808637.
Braack L, Wulandhari SA, Chanda E, Fouque F, Merle CS, Nwangwu U, Velayudhan R, Venter M, Yahouedo AG, Lines J, Aung PP, Chan K, Abeku TA, Tibenderana J, Clarke SE. Developing African arbovirus networks and capacity strengthening in arbovirus surveillance and response: findings from a virtual workshop. Parasit Vectors 16(1):129, 2023. PMID: 37059998.
Hana C, Rehman T, Park K, Carracedo Uribe C, Aung PP, Hunis B, Salzberg M, Zikria J, Hussein A. Pancreatic adverse events in patients treated with immune checkpoint inhibitors. JGH Open 7(3):204-207, 2023. PMID: 36968572.
Rothrock AT, Hameed N, Cho WC, Nagarajan P, Ivan D, Torres-Cabala CA, Prieto VG, Curry JL, Aung PP. BRAF V600E immunohistochemistry as a useful tool in the diagnosis of melanomas with ambiguous morphologies and immunophenotypes. J Cutan Pathol 50(3):223-229, 2023. e-Pub 2022. PMID: 36377266.
Lewis A, Thant AA, Aslam A, Aung PPM, Azmi S. Diagnosis and management of adrenal insufficiency. Clin Med (Lond) 23(2):115-118, 2023. PMID: 36958832.
Pemmaraju N, Kantarjian H, Sweet K, Wang E, Senapati J, Wilson NR, Konopleva M, Frankel AE, Gupta V, Mesa R, Ulrickson M, Gorak E, Bhatia S, Budak-Alpdogan T, Mason J, Garcia-Romero MT, Lopez-Santiago N, Cesarman-Maus G, Vachhani P, Lee S, Bhatt VR, Blum W, Walter RB, Bixby D, Gojo I, Duvic M, Rampal RK, de Lima M, Foran J, Fathi AT, Hall AC, Jacoby MA, Lancet J, Mannis G, Stein AS, Mims A, Rizzieri D, Olin R, Perl A, Schiller G, Shami P, Stone RM, Strickland S, Wieduwilt MJ, Daver N, Ravandi F, Vasu S, Guzman M, Roboz GJ, Khoury J, Qazilbash M, Aung PP, Cuglievan B, Madanat Y, Kharfan-Dabaja MA, Pawlowska A, Taylor J, Tallman M, Dhakal P, Lane AA. North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need. Blood 141(6):567-578, 2023. e-Pub 2022. PMID: 36399715.
Li Y, Stewart K, Han KT, Han ZY, Aung PP, Thein ZW, Htay T, Chen D, Nyunt MM, Plowe CV. Understanding Spatiotemporal Human Mobility Patterns for Malaria Control Using a Multiagent Mobility Simulation Model. Clin Infect Dis 76(3):e867-e874, 2023. PMID: 35851600.
Borkenhagen LK, Aung PP, Htay T, Thein ZW, Tin OS, Mon TS, Myint W, Bailey ES, Wanninger TG, Kandeil AM, Webby RJ, Gray GC. A cross-sectional study of avian influenza A virus in Myanmar live bird markets: Detection of a newly introduced H9N2?. Influenza Other Respir Viruses 17(2):e13111, 2023. PMID: 36843223.
Rothrock AT, Torres-Cabala CA, Milton DR, Cho WC, Nagarajan P, Vanderbeck K, Curry JL, Ivan D, Prieto VG, Aung PP. Diagnostic utility of PRAME expression by immunohistochemistry in subungual and non-subungual acral melanocytic lesions. J Cutan Pathol 49(10):859-867, 2022. e-Pub 2022. PMID: 35794643.
Rothrock AT, Truong LD, Shehabeldin A, Wong MKK, Cho WC, Nagarajan P, Vanderbeck K, Curry JL, Torres-Cabala CA, Prieto VG, Aung PP. Amyloid deposition with a granulomatous reaction in a resection specimen: A clue for a preexisting Merkel cell carcinoma (**Publication with mentoring role**). J Cutan Pathol 49(9):787-790(9):787-790, 2022. PMID: 35734844.
Farah M, Milton D, Gross ND, Nagarajan P, Gu J, Curry JL, Ivan D, Torres-Cabala CA, Myers JN, Prieto VG, Aung PP. Histopathologic Features Predictive of Metastasis and Survival in 230 Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck and Non-Head and Neck Locations: A Single-Center Retrospective Study (**Publication with mentoring role**). J Eur Acad Dermatol Venereol 36(8):1246-1255(8):1246-1255, 2022. PMID: 35426183.
Kibbi N, Owen JL, Worley B, Wang JX, Harikumar V, Downing MB, Aasi SZ, Aung PP, Barker CA, Bolotin D, Bordeaux JS, Cartee TV, Chandra S, Cho NL, Choi JN, Chung KY, Cliby WA, Dorigo O, Eisen DB, Fujisawa Y, Golda N, Halfdanarson TR, Iavazzo C, Jiang SIB, Kanitakis J, Khan A, Kim JYS, Kuzel TM, Lawrence N, Leitao MM, MacLean AB, Maher IA, Mittal BB, Nehal KS, Ozog DM, Pettaway CA, Ross JS, Rossi AM, Servaes S, Solomon MJ, Thomas VD, Tolia M, Voelzke BB, Waldman A, Wong MK, Zhou Y, Arai N, Brackett A, Ibrahim SA, Kang BY, Poon E, Alam M. Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease. JAMA Oncol 8(4):618-628(4):618-628, 2022. PMID: 35050310.
Cho WC, Gill P, Nagarajan P, Aung PP, Torres-Cabala CA, Curry JL, Ivan D, Lester L, Prieto VG. Cutaneous Lymphoid Hyperplasia With T-Cell Clonality and Monotypic Plasma Cells Secondary to a Tick Bite: A Hidden Critter and the Power of Deeper Levels. Am J Dermatopathol 44(3):226-229(3):226-229, 2022. PMID: 35050559.
Aung PP, Wimmer DB, Lester TR, Tetzlaff MT, Prieto VG. Perianal condylomata lata mimicking squamous cell carcinoma (**Publication with mentoring role**). J Cutan Pathol 49(3)(3):209-214, 2022. PMID: 33470447.
El Hussein S, Wang W, Wang SA, Loghavi S, Wang X, Qiu L, Fang H, Medeiros LJ, Aung PP, Torres Cabala C, Jorgensen JL, Pemmaraju N, Khoury JD. Blastic plasmacytoid dendritic cell neoplasm with history of myeloma and concomitant acute undifferentiated leukemia. Leuk Lymphoma 62(13):3296-3299(13):3296-3299, 2021. PMID: 34304666.
Ronen S, Al-Rohil RN, Keiser E, Jour G, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Middleton LP, Torres-Cabala CA, Gershenwald JE, Aung PP, Prieto VG. Discordance in Diagnosis of Melanocytic Lesions and Its Impact on Clinical Management (**Publication with mentoring role**). Arch Pathol Lab Med (Featured Cover Image of the Journal Issue) 145(12):1505-1522, 2021. PMID: 33577643.
Wang M, Aung PP, Prieto VG. Standardized Method for Defining a 1-mm2 Region of Interest for Calculation of Mitotic Rate on Melanoma Whole Slide Images (**Publication with mentoring role**). Arch Pathol Lab Med 145(10):1255-1263, 2021. PMID: 33417687.
Cho WC, Gill P, Aung PP, Gu J, Nagarajan P, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. The utility of digital pathology in improving the diagnostic skills of pathology trainees in commonly encountered pigmented cutaneous lesions during the COVID-19 pandemic: A single academic institution experience. Ann Diagn Pathol 54:151807, 2021. PMID: 34418768.
Collins K, Gu J, Aung PP, Nagarajan P, Curry JL, Huen A, Ivan D, Prieto VG, Tetzlaff MT, Duvic M, Miranda RN, Vega F, Torres-Cabala CA. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders? (**Publication with a mentoring role**). Virchows Arch 479(2):377-383, 2021. PMID: 33604757.
Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Nagarajan P, Curry JL, Ciurea AM, Rubin AI, Hwu WJ, Prieto VG, Aung PP. Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma (**Publication with mentoring role**). Arch Pathol Lab Med 145(8):943-952, 2021. PMID: 33290520.
Cho WC, Wang WL, Milton DR, Ingram DR, Nagarajan P, Curry JL, Ivan D, Lazar AJ, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma(**Publication with mentoring role**). Arch Pathol Lab Med 145(7):842-850, 2021. PMID: 33053175.
Xu M, Tapia C, Hajjar J, Sabir S, Colen R, Nagarajan P, Aung PP, Gong J, Rodon J, Fu S, Stephen B, Roy-Chowdhuri S, Le H, Yang V, Zarifa A, Abdelsalam ME, Jhingran A, Javle M, Pant S, Carter B, Milton DR, Sun R, Karp DD, Koay EJ, Yang Y, Wistuba II, Hwu P, Meric-Bernstam F, Naing A. Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens. J Immunother Precis Oncol 4(2):45-52, 2021. e-Pub 2021. PMID: 35663531.
Kwon D, Ronen S, Giubellino A, Keiser E, Aung PP, Nagarajan P, Tetzlaff MT, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. Cutaneous adnexal carcinosarcoma: Immunohistochemical and molecular evidence of epithelial mesenchymal transition. J Cutan Pathol 4(48):526-534, 2021. PMID: 32564423.
Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Feldmeyer L, Namikawa K, Nagarajan P, Tetzlaff MT, Curry JL, Ross MI, Hwu WJ, Prieto VG, Aung PP. Prognostic significance of acral lentiginous histologic type in T1 melanoma (**Publication with mentoring role**). Mod Pathol 34(3):572-583, 2021. e-Pub 2020. PMID: 32759976.
Chin KE, Kwon D, Gan Q, Ramalingam PX, Wistuba II, Prieto VG, Aung PP. Transition From a Standard to a Hybrid On-Site and Remote Anatomic Pathology Training Model During the Coronavirus Disease 2019 (COVID-19) Pandemic (**Publication with mentoring role**). Arch Pathol Lab Med 145(1):22-31, 2021. PMID: 32937659.
Farah M, Reuben A, Spassova I, Yang RK, Kubat L, Nagarajan P, Ning J, Li W, Aung PP, Curry JL, Torres-Cabala CA, Hudgens CW, Ugurel S, Schadendorf D, Gumbs C, Little LD, Futreal A, Wistuba II, Prieto VG, Wang L, Wong MK, Wargo JA, Becker JC, Tetzlaff MT. T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma. J Invest Dermatol 140(11):2146-2156.e4, 2020. e-Pub 2020. PMID: 32304704.
Aung PP, Pemmaraju N, Torres-Cabala CA, Duvic M, Konopleva M, Khoury JD, Prieto VG. Apparent partial loss of CD123 expression in blastic plasmacytoid dendritic cell neoplasm after treatment with CD123-targeted therapy. J Dermatol 47(10):e354-e355, 2020. e-Pub 2020. PMID: 32770556.
Ramani NS, Aung PP, Gu J, Sfamenos S, Sdringola-Maranga C, Nagarajan, Tetzlaff MT, Curry JL, Ivan D, Diab A, Prieto VG, Hwu WJ, Torres-Cabala CA. TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis (**Publication with mentoring role**). Mod Pathol 33(10):2067-2074, 2020. e-Pub 2020. PMID: 32404956.
Gonzàlez-Farré M, Ronen S, Keiser E, Prieto VG, Aung PP. Three Types of Nodal Melanocytic Nevi in Sentinel Lymph Nodes of Patients with Melanoma: Pitfalls, Immunohistochemistry, and a Review of the Literature (**Publication with mentoring role**). Am J Dermatopathol 42(10):739-744, 2020. PMID: 32271206.
Vougiouklakis T, Aung PP, Vasudevaraja V, Prieto VG, Torres-Cabala CA, Sulman EP, Snuderl M, Jour G. Correlative study of epigenetic regulation of tumor microenvironment in spindle cell melanomas and cutaneous malignant peripheral nerve sheath tumors. Sci Rep 10(1):12996, 2020. PMID: 32747660.
Jenkinson HA, Aung PP, Huen A. Mycosis fungoides manifesting as a morbilliform eruption mimicking a viral exanthem. Cutis 105(6):E27-E29, 2020. PMID: 32717002.
Collins K, Prieto VG, Aung PP. Unusual Presentations of Primary and Metastatic Adenoid Cystic Carcinoma Involving the Skin (**Publication with mentoring role**). Am J Dermatopathol 42(12):967-971, 2020. PMID: 32618709.
Yildiz P, Aung PP, Milton DR, Hruska C, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala C, Prieto VG. Measurement of Tumor Thickness in Cutaneous Squamous Cell Carcinomas: Do the Different Methods Provide Better Prognostic Data? (**Publication with mentoring role**). Am J Dermatopathol 42(5):337-342, 2020. PMID: 31464719.
Chen PL, Neishaboori N, Tetzlaff MT, Chen WS, Aung PP, Curry JL, Nagarajan P, Ivan D, Hwu WJ, Prieto VG, Torres-Cabala CA. BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like Melanoma. (CME Article). Am J Dermatopathol 42(5):313-321, 2020. PMID: 32310893.
Tapia C, Aung PP, Roy-Chowdhuri S, Xu M, Ouyang F, Alshawa A, Hajjar J, Singh G, Yang V, Castillo L, Le H, Murthy R, Stephen B, Hess KR, Wistuba I, Naing A. Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors. J Immunother Cancer 8(1), 2020. PMID: 32303619.
Nagarajan P, Piao J, Ning J, Noordenbos LE, Curry JL, Torres-Cabala CA, Diwan AH, Ivan D, Aung PP, Ross MI, Royal RE, Wargo JA, Wang WL, Samdani R, Lazar AJ, Rashid A, Davies MA, Prieto VG, Gershenwald JE, Tetzlaff MT. Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features. Mod Pathol 33(3):496-513, 2020. e-Pub 2019. PMID: 31383963.
Namikawa K, Aung PP, Milton DR, Tetzlaff MT, Torres Cabala CA, Curry JL, Nagarajan P, Ivan D, Ross MI, Gershenwald JE, Prieto VG. Correlation of tumor burden in sentinel lymph nodes with tumor burden in non-sentinel lymph nodes and survival in cutaneous melanoma (**Publication with mentoring role**). Clin Cancer Res 25(24):7585-7593, 2019. PMID: 31570567.
Pradhan D, Jour G, Milton D, Vasudevaraja V, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Long L, Ding Y, Ezhilarasan R, Sulman EP, Diab A, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP. Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma (**Publication with mentoring role**). Cancers 11(12), 2019. e-Pub 2019. PMID: 31888295.
Ruiz SJ, Al Salihi S, Prieto VG, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Torres-Cabala CA, Aung PP. Unusual cutaneous metastatic carcinoma (**Publication with mentoring role**). Ann Diagn Pathol 43:151399, 2019. PMID: 31675677.
Mejbel HA, Arudra SKC, Pradhan D, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Duose DY, Luthra R, Prieto VG, Ballester LY, Aung PP. Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic Heterogeneity (**Publication with mentoring role**). Cancers 11(11), 2019. PMID: 31684113.
Al Salihi, S, Mejbel, HA, Prieto, V, Aung, PP. Common Cutaneous Neoplasms in Patients with Immunodeficiency: A Case Series. Journal of Immunotherapy and Precision Oncology 2(3):79-84, 2019. PMID: None.
Sukswai N, Aung PP, Yin CC, Li S, Zheng X Wang W, Wang SA, Ortega V, Lyapichev K, Alfattal R, Angelove E, Tang Z, Loghavi S, Kanagal-Shammanna R, Miranda RM, Medeiros LJ, Khoury JD. Dual Expression of TCF4 and CD123 is Highly Sensitive and Specific for Blastic Plasmacytoid Dendritic Cell Neoplasm. Am J Surg Pathol 43(10):1429-1437, 2019. PMID: 31261288.
Tetzlaff MT, Tang S, Duke T, Cabanillas ME, Zuo Z, Nagarajan P, Aung PP, Torres-Cabala CA, Duvic M, Prieto VG, Heun A, Curry JL. Lichenoid dermatitis toxicity from checkpoint inhibitor therapy: An immune-related adverse event with mycosis fungoides-like morphologic and molecular features. J Cutan Pathol 46(11):872-877, 2019. PMID: 31254410.
Aung PP, Parra ER, Barua S, Sui D, Ning J, Mino B, Ledesma DA, Curry JL, Nagarajan P, Torres-Cabala CA, Efstathiou E, Hoang A, Wong MK, Wargo JA, Lazar AJ, Rao A, Prieto VG, Wistuba I, Tetzlaff MT. B7-H3 expression in Merkel cell carcinoma-associated endothelial cells correlates with locally aggressive primary tumor features and increased vascular density. Clinical Cancer Research 25(11):3455-3467, 2019. PMID: 30808776.
Kim DH, Medeiros LJ, Aung PP, Young KH, Miranda RN, Ok CY. Mantle Cell Lymphoma Involving Skin: A Clinicopathologic Study of 37 Cases. Am J Surg Pathol 43(10):1421-1428, 2019. PMID: 31219818.
Mauzo SH, Tetzlaff MT, Milton DR, Siroy AE, Nagarajan P, Torres-Cabala CA, Ivan D, Curry JL, Hudgens CW, Wargo JA, Sahin AA, Pettaway CA, Prieto VG, Aung PP. Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy (**Publication with mentoring role**). Cancers 11(6), 2019. PMID: 31146499.
Aung PP, Sukswai N, Nejati R, Loghavi S, Chen W, Torres-Cabala CA, Yin CC, Konopleva M, Zheng X, Wang J, Tang Z, Medeiros LJ, Prieto VG, Pemmaraju N, Khoury JD. PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers 11(5), 2019. e-Pub 2019. PMID: 31109153.
Erstine EM, Tetzlaff MT, Jia X, Aung PP, Prieto VG, Funchain P, Gastman BR, Billings SD, Ko JS. Prognostic Significance of "Nonsolid" Microscopic Metastasis in Merkel Cell Carcinoma Sentinel Lymph Nodes. Am J Surg Pathol 43(7):901-919, 2019. PMID: 31094923.
Kubicki SL, Park KE, Aung PP, Duvic M. Complete Resolution of Primary Cutaneous Anaplastic Large Cell Lymphoma with Topical Imiquimod. J Drugs Dermatol 18(5):460-462, 2019. PMID: 31141854.
Aung PP, Nagarajan P, Tetzlaff MT, Curry JL, Tang G, Abdullaev Z, Pack SD, Ivan D, Prieto VG, Torres-Cabala CA. Melanoma with Loss of BAP1 Expression in Patients with No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series. Am J Dermatopathol (CME Article) 41(3):167-179, 2019. PMID: 30801340.
Jour G, Vasudevaraja V, Prieto VG, Snuderl M, Torres-Cabala CA, Al-Rohil R, Sulman EP, Ballester LY, Aung PP. BCAT1 and MIR2054: Novel methylome signature distinguishes spindle/desmoplastic melanomas from superficial malignant peripheral nerve sheath tumors (**Publication with mentoring role**). Mod Pathol 32(3):338-345, 2019. PMID: 30310175.
Konopinski JC, Danialan R, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Prieto VG, Aung PP. Melanoma coexisting with solar elastosis. Hum Pathol 84:270-274, 2019. PMID: 30359637.
Al Salihi, S, Mejbel, HA, Prieto, V, Aung, PP. Common cutaneous neoplasms in patients with immunodeficiency. Journal of Immunotherapy and Precision Oncology 2(3):79-84, 2019. PMID: None.
Saenz-Ibarra B, Huen A, Nagarajan P, Torres-Cabala CA, Prieto VG, Aung PP. From mycosis fungoides to herpetic folliculitis: The significance of deeper H&E tissue sections in dermatopathology (**Publication with mentoring role**). J Cutan Pathol 46(8):624-626, 2019. PMID: 30883857.
Ronen S, Ivan D, Torres-Cabala CA, Curry JL, Tetzlaff MT, Aung PP, Nagarajan P, Sustera S, Prieto VG. Post-Radiation Vascular Lesions of the Breast. J Cutan Pathol 46(1):52-58, 2019. PMID: 30251277.
Al Salihi S, Mejbel HA, Prieto VG, Aung PP. Common cutaneous malignancies in patients with primary and secondary immune deficiencies and literature review (**Publication with mentoring role**). Journal of Immunotherapy and Precision Oncology 2(3):79-84, 2019. PMID: None.
Yildiz P, Ronen S, Aung PP, Trinidad C, Kajoian A, Prieto VG. Extramammary Paget Disease-A Challenging Case. Am J Dermatopathol 41(11):867-868, 2019. PMID: 30807292.
Riddell M, Nakayama A, Hikita T, Mirzapourshafiyi F, Kawamura T, Pasha A, Li M, Masuzawa M, Looso M, Steinbacher T, Ebnet K, Potente M, Hirose T, Ohno S, Fleming I, Gattenhohner S, Aung PP, Phung T, Yamasaki O, Yanagi T, Umemura H, Nakayama M. aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA binding ability. Nature Communications 9(1):5357, 2018. PMID: 30559384.
Curry JL, Tetzlaff MT, Wang SA, Landon G, Alouch N, Patel SP, Nagarajan P, Gupta S, Aung PP, Devine CE, Khoury JD, Loghavi S, Prieto VG, DiNardo C, Gershenwald JE. Case report of myeloid sarcoma masquerading as in-transit metastasis at a prior melanoma site: avoiding a diagnostic pitfall. Am J Dermatopathol 40(11):831-835, 2018. PMID: 29863571.
Tang Z, Li Y, Wang W, Yin CC, Tang G, Aung PP, Hu S, Lu X, Toruner GA, Medeiros LI, Khoury JD. Genomic Aberrations Involving 12p/ETV6 Are Highly Prevalent in Blastic Plasmacytoid Dendritic Cell Neoplasms and Might Represent Early Clonal Events. Leuk Res 73:86-94, 2018. PMID: 30248580.
Aria AB, Wilmas K, Kim EJ, Aung PP, Duvic M. The development of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder at the site of a melanoma excision scar. Dermatology Online Journal 24(9), 2018. PMID: 30677830.
Kubicki SL, Welborn ME, Garg N, Aung PP, Patel AB. Granulomatous dermatitis associated with ipilimumab therapy (Ipilimumab associated granulomatous dermatitis). J Cutan Pathol 45(8):636-638, 2018. PMID: 29704281.
Al-Rohil RN, Milton DR, Nagarajan P, Curry JL, Feldmeyer L, Torres-Cabala CA, Ivan D, Prieto VG, Tetzlaff MT, Aung PP. Intratumoral and Peritumoral Lymphovascular Invasion Detected by D2-40 Immunohistochemistry Correlates with Metastasis in Primary Cutaneous Merkel Cell Carcinoma (**Publication with mentoring role**). Hum Pathol 77:98-107, 2018. PMID: 29601841.
Buchely N, Al-Rohil RN, Aung PP, Jour G, Torres-Cabala CA, Prieto VG, Ivan D. Dermal xanthomatous infiltrates after Brentuximab Vedotin therapy in mycosis fungoides with large cell transformation. J Cutan Pathol 45(9):711-715, 2018. PMID: 29806104.
Emge DA, Lewis DJ, Aung PP, Duvic M. How to Discern Folliculotropic Mycosis Fungoides From Follicular Mucinosis Using a Pediatric Case (**Publication with mentoring role**). J Cutan Med Surg 22(3):336-340, 2018. PMID: 29318909.
Mauzo SH, Milton DR, Prieto VG, Torres-Cabala CA, Wang WL, Chakravarti N, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Brown RE, Aung PP. Summary of expression of SPARC protein in cutaneous vascular neoplasms and mimickers (**Publication with mentoring role**). Ann Diagn Pathol 34:151-154, 2018. PMID: 29660567.
Saenz-Ibarra B, Prieto VG, Torres-Cabala CA, Huen A, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Aung PP. Coccidioidomycosis Involving Lungs and Skin: A Mimicker of Metastatic Disease (**Publication with mentoring role**). Am J Dermatopathol 40(3):e41-e43, 2018. e-Pub 2017. PMID: 28857979.
Namikawa K, contribution) AP, Milton DR, Gershenwald JE, (*equal contribution) PV. Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Cancer Medicine 7(3):583-593, 2018. PMID: 29464914.
Chan WH, Lewis DJ, Kim EJ, Aung PP, Duvic M. Generalized morphea/eosinophilic fasciitis overlap after epoxy exposure. JAAD Case Rep 4(2):175-178, 2018. PMID: 29892660.
Emge DA, Lewis DJ, Aung PP. Eosinophilic cellulitis (Well syndrome) in a patient with mycosis fungoides. (**Publication with mentoring role**). Dermatology Online Journal 24(1), 2018. PMID: 29469767.
Jour G, Aung PP, Merrill ED, Curry JL, Tetzlaff MT, Nagarajan P, Ivan D, Prieto VG, Duvic M, Miranda RN, Torres-Cabala CA. Differential expression of CCR4 in primary cutaneous gamma/delta (γ/δ) T cell lymphomas and mycosis fungoides. J Dermatol Sci 89(88-91):88-91, 2018. e-Pub 2017. PMID: 29030090.
Jour G, Andeen NK, Al-Rohil RA, Aung PP, Mehrotra M, Duose D, Hoch B, Argenyi Z, Luthra R, Wistuba II, Prieto VG. Novel enriched pathways in superficial malignant peripheral nerve sheath tumors (MPNST) and spindle/desmoplastic melanomas (SDM). J Pathol 244(1):97-106, 2018. e-Pub 2017. PMID: 28991373.
Mauzo SH, Tetzlaff MT, Nelson K, Amaria R, Patel S, Aung PP, Nagarajan P, Torres-Cabala CA, Diab A, Prieto VG, Curry JL. Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade. Int J Dermatol 58(9):1045-1052, 2017. PMID: 29152725.
Shustef E, Torres-Cabala CA, Curry JL, Tetzlaff MT, Nagarajan P, Ivan D, Prieto VG, Aung PP. Intraepithelial Melanoma in the Stomach After Treatment with Immune Checkpoint Blockade Therapy (**Publication with mentoring role**). Am J Dermatopathol 39(8):e116-e118, 2017. e-Pub 2017. PMID: 28248716.
Jour G, Aung PP, Rozas-Muñoz E, Curry JL, Prieto V, Ivan D. Intraepidermal Merkel cell carcinoma: a case series of a rare entity with clinical follow-up (**Publication with mentoring role**). J Cutan Pathol 44(8):468-470, 2017. e-Pub 2017. PMID: 28543532.
Konopinski J, Prieto VG, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala CA, Fuller GN, Aung PP. Isolated Ectopic Cutaneous Atypical Meningioma of the Scalp: Another Mimicker of Primary Adnexal Tumor (**Publication with mentoring role**). Am J Dermatopathol 39(7):545-547, 2017. e-Pub 2017. PMID: 28178009.
Aung PP, Rady PL, Nagarajan P, Ivan D, Tetzlaff MT, Curry JL, Tyring SK, Prieto VG, Torres-Cabala CA. Detection of Merkel Cell Polyoma Virus and Beta Human Papillomavirus in Multiple Eccrine Poromas in a Patient with Acute Leukemia Treated With Stem Cell Transplant. Am J Dermatopathol 39(6):489-491, 2017. e-Pub 2016. PMID: 27655121.
Valero-Torres A, Prieto VG, Nagarajan P, Torres-Cabala CA, Tetzlaff MT, Curry JL, Ivan D, Aung PP. Metastatic Melanoma with Papillary Features: A Mimic and Possible Diagnostic Pitfall (**Publication with mentoring role**). Am J Dermatopathol 39(6):468-470, 2017. PMID: 28525424.
Pina-Oviedo S, Torres-Cabala CA, Miranda RN, Tetzlaff MT, Singh S, Rapini RP, Prieto VG, Aung PP. Concomitant Cutaneous Langerhans Cell Histiocytosis and Leukemia Cutis. (**Publication with mentoring role**). Am J Dermatopathol 39(5):388-392, 2017. e-Pub 2016. PMID: 27759701.
Nagarajan P, Curry JL, Ning J, Piao J, Torres Cabala CA, Aung PP, Ivan D, Ross MI, Levenback CF, Frumovitz M, Gershenwald JE, Davies MA, Malpica A, Prieto V, Tetzlaff MT. Tumor thickness and mitotic rate robustly predict melanoma-specific survival in patients with primary vulvar melanoma: A retrospective review of 100 cases. Clin Cancer Res 23(8):2093-2104, 2017. e-Pub 2016. PMID: 27864417.
Agbay RL, Torres-Cabala CA, Patel KP, Merril ED, Duvic M, Quesada A, Prieto VG, Aung PP, Loghavi S, Young KH, Hu S, Ferrufino-Schmidt MC, Tetzlaff M, Li S, Medeiros LJ, Miranda RN. Immunophenotypic Shifts in Primary Cutaneous γδ T-Cell Lymphoma Suggest Antigenic Modulation: A Study of Sequential Biopsy Specimens. Am J Surg Pathol 41(4):431-445, 2017. e-Pub 2017. PMID: 28248813.
Merrill ED, Agbay R, Miranda RN, Aung PP, Tetzlaff MT, Young KH, Curry JL, Nagarajan P, Ivan D, Prieto VG, Medeiros LJ, Duvic M, Torres-Cabala CA. Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (γδ) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous γδ T-Cell Lymphomas. Am J Surg Pathol 41(2):204-215, 2017. e-Pub 2016. PMID: 27879514.
Tetzlaff MT, Nagarajan P, Chon S, Huen A, Diab A, Omar P, Aung PP, Torres-Cabala CA, Mays SR, Prieto VG, Curry JL. Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features. Am J Dermatopathol 39(2):121-129, 2017. PMID: 28134729.
Siroy AE, Aung PP, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Milton DR, Curry JL, Ivan D, Prieto VG. Clinical Significance of BRAF V600E Mutational Status in Capsular Nevi of Sentinel Lymph Nodes in Patients with Primary Cutaneous Melanoma (**Publication with mentoring role**). Hum Pathol 59:48-54, 2017. e-Pub 2016. PMID: 27666765.
Feldmeyer L, Hudgens CW, Ray-Lyons G, Nagarajan P, Aung PP, Curry JL, Torres-Cabala CA, Mino B, Rodriguez-Canales J, Reuben A, Chen PL, Ko JS, Billings SD, Bassett RL, Wistuba II, Cooper ZA, Prieto VG, Wargo JA, Tetzlaff MT. Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma. Clin Cancer Res 22(22):5553-5563, 2016. PMID: 27166398.
Ramani NS, Curry JL, Merrill ED, Aung PP, Prieto VG, Tetzlaff MT, Duvic M, Miranda R, Torres-Cabala C. Primary cutaneous Gamma-Delta T-cell lymphoma: An unusual case with very subtle histopathological findings. Am J Dermatopathol 38(10):e147-9, 2016. PMID: 27533072.
Al-Rohil RN, Curry JL, Torres-Cabala CA, Nagarajan P, Ivan D, Aung PP, Lyons GF, Bassett RL, Prieto VG, Tetzlaff MT. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors. Hum Pathol 53:73-81, 2016. PMID: 27004944.
Feldmeyer L, Tetzlaff M, Fox P, Nagarajan P, Curry J, Ivan D, Torres Cabala CA, Prieto VG, Aung PP. Prognostic Implication of Lymphovascular Invasion Detected by Double Immunostaining for D2-40 and MITF1 in Primary Cutaneous Melanoma. (**Publication with mentoring role**). Am J Dermatopathol 38(7):484-91, 2016. e-Pub 2015. PMID: 26675354.
Jour, G, Ivan, D, Aung, PP. Updates in Molecular Dermatopathology: from diagnostics to theranostics. Global Dermatology 3(4):352-358, 2016. PMID: None.
Feldmeyer L, Moon BS, Prieto VG, Aung PP. Role of Radiotherapy in Aggressive Digital Papillary Adenocarcinoma. (**Publication with mentoring role**). Annals of Clinical and Laboratory Science 46 (2)(2):222-4, 2016. PMID: 27098633.
Bell, D, Aung, PP, Prieto, V, Ivan, D. Next-generation sequencing reveals rare genomic alterations in aggressive digital papillary adenocarcinoma. Annals of Diagnostic Pathology 19(6):381-384, 2015. PMID: 26386519.
Bell D, Aung PP, Prieto VG, Ivan D. Next-generation sequencing reveals rare genomic alterations in aggressive digital papillary adenocarcinoma. Ann Diagn Pathol 19(6):381-4, 2015. PMID: None.
Aung PP, Ballester LY, Goldberg LJ, Bhawan J. Incidental simultaneous finding of intravascular histiocytosis and reactive angioendotheliomatosis: a case report. Am J Dermatopathol 37(5):401-4, 2015. PMID: 25503604.
Aung PP, Leone D, Feller JK, Yang S, Hernandez M, Yaar R, Singh R, Helm T, Mahalingam M. Microvessel density, lymphovascular density, and lymphovascular invasion in primary cutaneous melanoma-correlation with histopathologic prognosticators and BRAF status. Hum Pathol 46(2):304-12, 2015. e-Pub 2014. PMID: 25537974.
Aung PP, Goldberg LJ, Mahalingam M, Bhawan J. Cutaneous Myopericytoma: A Report of 3 Cases and Review of the Literature. Dermatopathology (Basel) 2(1):9-14, 2015. PMID: 27047931.
Dong Y, Richards JA, Gupta R, Aung PP, Emley A, Kluger Y, Dogra SK, Mahalingam M, Wajapeyee N. PTEN functions as a melanoma tumor suppressor by promoting host immune response. Oncogene 33(38):4632-42, 2014. PMID: 24141770.
Aung PP, Bowker B, Masterpol KS, Mahalingam M. Disseminated noninterstitial granulomatous dermatitis as a cutaneous manifestation of the preleukemic state in a patient with myelodysplasia and ulcerative colitis--apropos a case and review of the literature. Am J Dermatopathol 36(7):e117-20, 2014. PMID: 24950421.
Aung PP, Batrani M, Mirzabeigi M, Goldberg LJ. Extraocular sebaceous carcinoma in situ: report of three cases and review of the literature. J Cutan Pathol 41(7):592-6, 2014. PMID: 24666211.
Aung PP, Ballester LY, Mahalingam M. Histopathology of Keratoacanthoma Revisited: Utility of Orificial Size as a Diagnostic Adjunct. Int J Surg Pathol 22(4):316-325, 2014. e-Pub 2014. PMID: 24284133.
Aung PP, Liu YC, Ballester LY, Robbins PF, Rosenberg SA, Lee CC. Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma. Hum Pathol 45(2):259-67, 2014. PMID: 24290058.
Ballester LY, Aung PP, Lai J, Nobregal R, Wang Z, Miettinen M, Warren K, Quezado M. Expression status of IDH1 mutant and SDHB genes in adult and pediatric gliomas. International Journal of Neuropathology 2(1):17-23, 2014. PMID: None.
Aung PP, Burns SJ, Bhawan J. Lichen aureus: an unusual histopathological presentation: a case report and a review of literature. Am J Dermatopathol 36(1):e1-4, 2014. PMID: 23656907.
Aung PP, Batrani M, Yang S, Mahalingam M. Apoptosis and in situ and invasive squamous cell carcinoma in sun-exposed sites. Am J Dermatopathol 35(8):797-803, 2013. PMID: 23455334.
Alimchandani M, Lai JP, Aung PP, Khangura S, Kamal N, Gallin JI, Holland SM, Malech HL, Heller T, Miettinen M, Quezado MM. Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients. Am J Surg Pathol 37(9):1365-72, 2013. PMID: 23887163.
Lai JP, Liu YC, Alimchandani M, Liu Q, Aung PP, Matsuda K, Lee CC, Tsokos M, Hewitt S, Rushing EJ, Tamura D, Levens DL, Digiovanna JJ, Fine HA, Patronas N, Khan SG, Kleiner DE, Oberholtzer JC, Quezado MM, Kraemer KH. The influence of DNA repair on neurological degeneration, cachexia, skin cancer and internal neoplasms: autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D). Acta Neuropathol Commun 1(1):4, 2013. PMID: 24252196.
Aung PP, Killian K, Poropatich CO, Linehan WM, Merino MJ. Primary neuroendocrine tumors of the kidney: morphological and molecular alterations of an uncommon malignancy. Hum Pathol 44(5):873-80, 2013. PMID: 23199527.
Ballester, L, Aung, PP, Lai, JP, Digiovanna, JJ, Abdullaev, Z, Pack, SD, Linehan, WM, Stern, JB, Pinto, PA, Lee, CR. An unusual presentation of glomeruloid hemangioma in a patient with VHL syndrome: A case report and review of literature. Open Journal of Clinical Diagnostics 3(2):63-66, 2013. PMID: None.
Timur AA, Murugesan G, Zhang L, Aung PP, Barnard J, Wang QK, Gaussem P, Silverstein RL, Bhatt DL, Kottke-Marchant K. P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease. Int J Lab Hematol 34(5):473-83, 2012. PMID: 22574824.
Lai JP, Robbins PF, Raffeld M, Aung PP, Tsokos M, Rosenberg SA, Miettinen MM, Lee CC. NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis. Mod Pathol 25(6):854-8, 2012. PMID: 22388761.
Aung PP, Sarlomo-Rikala M, Lasota J, Lai JP, Wang ZF, Miettinen M. KBA62 and PNL2: 2 new melanoma markers-immunohistochemical analysis of 1563 tumors including metastatic, desmoplastic, and mucosal melanomas and their mimics. Am J Surg Pathol 36(2):265-72, 2012. PMID: 22067329.
Sanchez JA, Krumroy L, Plummer S, Aung PP, Merkulova A, Skacel M, DeJulius KL, Manilich E, Church JM, Casey G, Kalady MF. Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer. Br J Surg 96(10):1196-204, 2009. PMID: 19787768.
Fukuyama R, Niculaita R, Ng KP, Obusez E, Sanchez J, Kalady M, Aung PP, Casey G, Sizemore N. Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription. Oncogene 27(46):6044-55, 2008. PMID: 18591935.
Koo BH, Hurskainen T, Mielke K, Aung PP, Casey G, Autio-Harmainen H, Apte SS. ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer. Int J Cancer 121(8):1710-6, 2007. PMID: 17597111.
Zhao Z, Xiao Y, Elson P, Tan H, Plummer SJ, Berk M, Aung PP, Lavery IC, Achkar JP, Li L, Casey G, Xu Y. Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer. J Clin Oncol 25(19):2696-701, 2007. PMID: 17602074.
Aung PP, Oue N, Mitani Y, Nakayama H, Yoshida K, Noguchi T, Bosserhoff AK, Yasui W. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene 25(17):2546-57, 2006. PMID: 16331256.
Aung PP, Mitani Y, Sanada Y, Nakayama H, Matsusaki K, Yasui W. Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas. Virchows Arch 448(4):428-34, 2006. e-Pub 2005. PMID: 16328347.
Aung PP, Matsumura S, Kuraoka K, Kunimitsu K, Yoshida K, Matsusaki K, Nakayama H, Yasui W. No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population. Oncol Rep 14(5):1151-4, 2005. PMID: 16211278.
Oue N, Mitani Y, Aung PP, Sakakura C, Takeshima Y, Kaneko M, Noguchi T, Nakayama H, Yasui W. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. J Pathol 207(2):185-98, 2005. PMID: 16086444.
Shutoh M, Oue N, Aung PP, Noguchi T, Kuraoka K, Nakayama H, Kawahara K, Yasui W. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation. Cancer 104(8):1609-19, 2005. PMID: 16134180.
Mizuiri H, Yoshida K, Toge T, Oue N, Aung PP, Noguchi T, Yasui W. DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage. Cancer Sci 96(9):571-7, 2005. PMID: 16128742.
Motoshita J, Oue N, Nakayama H, Kuraoka K, Aung PP, Taniyama K, Matsusaki K, Yasui W. DNA methylation profiles of differentiated-type gastric carcinomas with distinct mucin phenotypes. Cancer Sci 96(8):474-9, 2005. PMID: 16108828.
Mitani Y, Oue N, Hamai Y, Aung PP, Matsumura S, Nakayama H, Kamata N, Yasui W. Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma. J Pathol 205(1):65-73, 2005. PMID: 15586362.
Yasui W, Oue N, Shuto M, Aung PP. Gene expression profiling in stomach cancer and its clinical application. Nihon Naika Gakkai Zasshi 94(1):25-30, 2005. PMID: 15685870.
Oue N, Aung PP, Mitani Y, Kuniyasu H, Nakayama H, Yasui W. Genes involved in invasion and metastasis of gastric cancer identified by array-based hybridization and serial analysis of gene expression. Oncology 69 Suppl 1(SUPPL. 1):17-22, 2005. PMID: 16210872.
Oue, N, Hamai, Y, Mitani, Y, Matsumura, S, Oshimo, Y, Aung, PP, Kuraoka, K, Nakayama, H, Yasui, W. Gene Expression Profile of Gastric Carcinoma. Cancer Research 64(7):2397-2405, 2004. PMID: 15059891.
Bakshi N, Al Hejazi A, Mugarairi a, Alottaibi AS, Khogeer HA, Seliem RM, Pandita R, Rasian H, Aung PP, Ohgami R. A multidisciplinary approach to diagnosing blastic plasmacytoid denddritic cell neoplasm (BPDCN): Practical recommendations and insights from countries of the Gulf Cooperation Council. Critical Reviews in Oncology/Hematology None(None):None. PMID: None.

Invited Articles

Donnelly D 3rd, Aung PP, Jour G. The"-Omics" Facet of Melanoma: Heterogeneity of Genomic, Proteomic and Metabolomic Biomarkers. Semin Cancer Biol 59:165-174, 2019. PMID: 31295564.
Cho WC, Jour G, Aung PP. Role of angiogenesis in melanoma progression. Semin Cancer Biol 59:175-186, 2019. PMID: 31255774.
Trinidad C, Torres-Cabala CA, Prieto VG, Aung PP. Update on 8th-edition American Joint Committee on Cancer Classification for Merkel Cell Carcinoma and Histopathologic Parameters that Determine Prognosis (**Publication with mentoring role**). J Clin Pathol 72(5):337-340, 2019. PMID: 30636696.
Trinidad C, Prieto VG, Aung PP. Update on Staging of Cutaneous Melanoma and Pitfalls in Histologic Examination of Staging Parameters. J Clin Pathol (**Publication with mentoring role**) 72(4):265-270, 2019. PMID: 30275100.
Zorofchian S, Iqbal F, Rao M, Aung PP, Esquenazi Y, Ballester LY. Circulating Tumor DNA, microRNA, and Metabolites in Cerebrospinal Fluid as Biomarkers for Central Nervous System Malignancies. J Clin Pathol 72(4):271-280, 2019. PMID: 30467241.
Shustef E, Kazlouskaya V, Prieto VG, Ivan D, Aung PP. Cutaneous angiosarcoma: a current update. J Clin Pathol (**Publication with mentoring role**) 70(11):917-925, 2017. PMID: 28916596.
Aung PP, Nagarajan P, Prieto VG. Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance. Lab Invest 97(6):657-668, 2017. e-Pub 2017. PMID: 28240749.
Jour G, Ivan D, Aung PP. Updates in Molecular Dermatopathology: from diagnostics to theranostics. In special issue "Update in Dermatopathology". Journal of Global Dermatology (**Publication with mentoring role**) 3(4):352-358, 2016. PMID: None.
Jour G, Ivan D, Aung PP. Angiogenesis in melanoma: an update with a focus on current targeted therapies. J Clin Pathol (**Publication with mentoring role**) 69(6):472-83, 2016. e-Pub 2016. PMID: 26865640.
Mauzo SH, Ferrarotto R, Bell D, Torres-Cabala CA, Tetzlaff MT, Prieto VG, Aung PP. Molecular characteristics and potential therapeutic targets in Merkel cell carcinoma (**Publication with mentoring role**). J Clin Pathol (Featured Cover Image of the Journal Issue) 69(5):382-90, 2016. PMID: None.
Danialan R, Mutyambizi KK, Aung PP, Prieto VG, Ivan D. Challenges in the diagnosis of cutaneous adnexal tumors. J Clin Pathol 68(12):992-1002, 2015. PMID: 26602416.
Aung PP, Mutyambizi KK, Danialan R, Ivan D, Prieto VG. Differential diagnosis of heavily pigmented melanocytic lesions: Challenges and diagnostic approach. (**Publication with mentoring role**). J Clin Pathol 68(12):963-70, 2015. PMID: 26602414.

Manuals, Teaching Aids, Other Teaching Publications

Aung PP, Cunningham CR. Solitary Fibrous Tumor (**Publication with mentoring role**) PIP-A Performance Improvement Program in Surgical Pathology (CME Eligible): College of American Pathology (CAP): CME Self-Assessment Module. None, 2024.
Aung PP, Liu YA. Cutaneous neurofibroma, diffuse type (**Publication with mentoring role**). DPATH-A Dermatopathology Program (SAM eligible): College of American Pathology (CAP): SAME Self-Assessment Module. None, 2024.
Aung PP, Cunningham CR. Malignant peripheral nerve sheath tumor (**Publication with mentoring role**) PIP-C Performance Improvement Program in Surgical Pathology (CME Eligible): College of American Pathology (CAP): CME Self-Assessment Module. None, 2024.
Aung PP, Law T. Invasive Mammary Paget Disease and Ductal Carcinoma In Situ Involving Lactiferous ducts, College of American Pathologists (CAP) Surgical Pathology Committee. VBP-C Virtual Biopsy Program. None, 2023.
Aung PP, Ronen S. Spindle cell squamous cell carcinoma (**Publication with mentoring role**) PIP-B Performance Improvement Program in Surgical Pathology (CME Eligible): College of American Pathology (CAP): CME Self-Assessment Module. None, 2023.
Aung PP, Lenskaya V. Fixed drug reaction (**Publication with mentoring role**). DPATH-A Dermatopathology Program (SAM eligible): College of American Pathology (CAP): SAM Self-Assessment Module. None, 2022.
Aung PP, Lenskaya V. Lupus panniculitis (**Publication with mentoring role**). DPATH-A Dermatopathology Program (SAM eligible): College of American Pathology (CAP): SAM-Assessment Module. None, 2022.
Aung PP, Maloney N. Neurofibroma (**Publication with mentoring role**). PIP-D Performance Improvement Program in Surgical Pathology (CME eligible): College of American Pathology (CAP): CME Self-Assessment Module. None, 2022.
Aung PP, Maloney N. Elastofibroma (**Publication with mentoring role**) PIP-A Performance Improvement Program in Surgical Pathology (CME eligible): College of American Pathology (CAP): CME Self-Assessment Module. None, 2022.
Aung PP, Keiser E. Malignant melanoma (small intestine) (**Publication with mentoring role **). PIP-A Performance Improvement Program in Surgical Pathology (CME eligible), 2021.
Aung PP, Cho WC. Endocrine Mucin-producing Sweat Gland Carcinoma (**Publication with mentoring role**). VBP-C Virtual Biopsy Program in Surgical Pathology College of American Pathology (CAP): SAM Self-Assessment Module, 2021.
Aung PP, Gill P. Atypical fibroxanthoma (**Publication with mentoring role**). DPATH-A Dermatopathology Program (SAM eligible): College of American Pathology (CAP): SAM Self-Assessment Module, 2021.
Aung PP, Gill P. Atypical Fibroxanthoma (**Publication with mentoring role**). PathologyOutlines.com website, 2021.
Aung PP, Warmke L. Malignant solitary fibrous tumor (inguinal region) (**Publication with mentoring role**). PIP-A Performance Improvement Program in Surgical Pathology (CME eligible), 2021.
Aung PP. New Faculty Orientation Resource Manual, Department of Pathology, Division of Pathology and Lab Medicine. None, 2021.
Aung PP, Kojima Y. Metastatic adenocarcinoma in soft tissue of pelvis from prostate primary (**Publication with mentoring role**) PIP-C Performance improvement Program in Surgical Pathology (CME eligible): College of American Pathology (CAP). None, 2020.
Aung PP, Ronen S. Sentinel lymph node biopsy for melanoma (**Publication with mentoring role**). VBP-C Virtual Biopsy Program in Surgical Pathology (SAM eligible): College of American Pathology (CAP), 2020.
Aung PP, Lindholm K. Diffuse large B-Cell Lymphoma, NOS (Colon) (**Publication with mentoring role**). PIP-A Performance Improvement Program in Surgical Pathology (CME eligible): College of American Pathology (CAP), 2020.
Aung PP, al E. Development and implementation of hybrid training curriculum for Pathology Fellows during COVID-19 pandemic. None, 2020.
Vasa P, Aung PP. Endocrine mucin- producing sweat gland carcinoma (EMPSGC) (**Publication with mentoring role **). American Society for Clinical Pathology (ASCP) Surgical Pathology Case Study, 2020.
Aung PP, Patel VR. Lipoma (**Publication with mentoring role**). PIP-B Performance Improvement Program in Surgical Pathology (CME eligible), 2019.
Aung PP, Bah I. Mycosis Fungoides/Sezary Syndrome (**Publication with mentoring role**). HPATH-A Hematopathology Program in Surgical Pathology (SAM eligible), 2019.
Aung PP, Patel VR. Epithelioid angiosarcoma (Breast) (**Publication with mentoring role**). PIP-B Performance Improvement Program in Surgical Pathology (CME eligible): College of American Pathology (CAP). PIP-B Performance Improvement Program in Surgical Pathology (CME eligible), 2019.
Aung PP, Gan Q. Cutaneous Candida Tropicalis Infection (**Publication with mentoring role**). VBP-D Virtual Biopsy Program in Surgical Pathology (SAM eligible): College of American Pathology (CAP), 2018.

Book Chapters

Ronen S, Aung PP. Molecular Pathology of Merkel Cell Carcinoma (**Publication with mentoring role**). In: Precision Molecular Pathology of Non-Melanocytic Entities. None. Springer Publishing, None, 2022.
Ronen S, Gill P, Aung PP. Melanocytic lesions associated with germ-line mutations: familial melanoma, BAP1-deficient lesions (**Publication with mentoring role**). In: Precision Molecular Pathology of Non-Melanocytic Lesions. None. Springer Publishing, None, 2022.
Jour G, Torres-Cabala CA, Aung PP. Molecular Biomarkers applied to diagnosis, prognosis, and treatment of Melanoma Patients (**Publication with mentoring role**). In: Precision Molecular Pathology of Non-Melanocytic Lesions. None. Springer Publishing, None, 2022.
Thomas, V, Aung, PP, Rapini, RP. Dermatopathology, 309-331, 2021.
Aung PP, Thomas V, Rapini RP. Frozen Sections in Dermatopathology. In: Frozen Section in Pathology. None. Springer Nature International Publishing, 309-331, 2021.
Torres Cabala, CA, Tetzlaff, M, Nagarajan, P, Ivan, D, Curry, JL, Aung, PP, Prieto, V. Skin, 3-227, 2020.
Aung PP. Cutaneous neural lesions and Merkel cell carcinoma, part of Skin session. In: In: Oncological Surgical Pathology. None. Springer International Publishing AG, 3-227, 2020.
Pradhan, D, Aung, PP. Muscle related neoplasm, None, 2019.
Pradhan D, Aung PP. Muscle related neoplasm. In: Dermatopathology for Residents. Neoplastic Dermatopathology. Chapter 6 (**Publication with mentoring role**). None. PathPresenter Publications, None, 2019.
Ballester, L, Aung, PP, Lee, CR. The MAPK Pathway in Melanoma, 151-163, 2016.
Ivan, D, Prieto, V, Aung, PP. Use of immunohistochemical and molecular studies in the evaluation of the sebaceous neoplasms, 81-99, 2016.
Torres-Cabala CA, Aung PP, Miranda RN, Curry JL. Immunohistology and Molecular Studies of Cutaneous T-cell Lymphomas and Mimics. In: In Applied Immunohistochemistry in the Evaluation of Skin Neoplasms. None. Springer Publishing, 229-259, 2016.
Torres Cabala, CA, Aung, PP, Miranda, R, Curry, JL. Immunohistology and molecular studies of cutaneous t-cell lymphomas and mimics, 229-259, 2016.
Ballester LY, Aung PP, Lee CR. MAPK Pathway in Melanoma. In: In Genetics of Melanoma. None. Springer Publishing, 151-163, 2016.
Ivan D, Prieto VG, Aung PP. Use of Immunohistochemistry and molecular studies in the evaluation of sebaceous neoplasms. In: Applied Immunohistochemistry in the Evaluation of Skin Neoplasms. Chapter 4, 1. None. Springer International Publishing AG, 81-99, 2016.
Ivan, D, Aung, PP. Molecular Pathology of Cutaneous Adnexal Tumors, 55-80, 2015.
Ivan D, Aung PP. Molecular pathology of Cutaneous Adnexal Tumors. In: In Precision Molecular Pathology of Dermatologic Diseases. None. Springer Publishing, 55-80, 2015.
Aung, PP, Mahalingam, M. Nodular B-lymphocyte reactive patterns, 207-230, 2014.
Aung PP, Mahalingam M. Nodular B lymphocyte reactive pattern. In: In Cutaneous Hematopathology. None. Springer Publishing, 207-230, 2014.

Letters to the Editor

Ravishankar S, Nagarajan P, Curry JL, Tetzlaff MT, Ivan D, Torres-Cabala CA, Aung PP, Prieto VG. Giemsa is the optimal counterstain for immunohistochemical detection of BRAF V600E mutation status in pigmented melanomas. Journal of Cutaneous Pathology 43: 722-4, 2016.

Less

Grant & Contract Support

Title:	Challenges of Pathology Fellows: Middle-child syndrome (Project with mentoring role)
Funding Source:	The University of Texas MD Anderson Cancer Center/Department of Pathology
Role:	PI

Title:	The Role of Acetylcholine Receptors in Merkel Cell Polyoma Virus-induced Merkel Cell Carcinoma from Various Ethnicities
Funding Source:	U54-NIH/NCI
Role:	Co-PI

Title:	Immunohistochemical Characterization of Trichorhinophalangeal Syndrome Type 1 (TPRS1) in Cutaneous Adnexal and Mon-Melanocytic Epithelial Neoplasms (Project with mentoring role)
Funding Source:	The University of Texas MD Anderson Cancer Center/Division of Pathology and Lab Medicine
Role:	Co-PI

Title:	Metabolomic Signature of Acral Melanoma (Project with mentoring role)
Funding Source:	The University of Texas MD Anderson Cancer Center/Department of Pathology
Role:	PI

Title:	Development of advanced machine (deep) learning algorithms to rapidly detect and accurately estimate the percentage of melanocytes expressing Mart1-Ki67 in borderline melanocytic lesions, and PDL1 in tumor cells, using double staining with tumor specific makers, Oncological Data and Computational Sciences sponsored by The Oden Institute for Computational Engineering and Sciences (Oden Institute)
Funding Source:	The University of Texas MD Anderson Cancer Center (MD Anderson), and Texas Advanced Computing Center (TACC)
Role:	PI

Title:	Molecular Characterization of Rare Cutaneous Neoplasms
Funding Source:	The Shirley Stein Endowment Research Grant
Role:	PI

Title:	Targeting a Stress-Derived Immunosuppressive Adenosine Pathway in Tumors Resistant to Checkpoint Inhibitors (W81XWH-19-1-0282-DOD Idea Award)
Funding Source:	Department of Defense (DOD)
Role:	Co-PI

Title:	Primary Acral Melanoma from Various Ethnicities: Comprehensive Molecular and Immune Profiling. Young Investigator Award
Funding Source:	Melanoma Research Alliance
Role:	PI

Title:	Development of personalized combinatorial strategies targeting apoptotic machinery in melanoma
Funding Source:	U54-NIH/NCI (5U54CA224070-03)
Role:	Co-PI

Title:	A phase 2, Open-Label Study Evaluating the Safety and Efficacy of KRT-232 in Patients with p53 Wild-Type (p53wt) Merkel Cell Carcinoma (MCC) Who Have Failed Anti-PD-1 or Anti-PD-L1 Immunotherapy, or in Combination with Avelumab in MCC Patients who are Anti-PD-1 or Anti-PD-L1 Treatment Naive, KRT-232-103
Funding Source:	Funded by Kartos Therapeutics, Inc
Role:	Collaborator

Title:	Phase 2 Clinical Trial for Comprehensive Treatment Program for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Tagraxofusp (SL-401) in Combination with HCVAD/Mini-CVD and VENETOCLAX
Funding Source:	Funded by APOLLO
Role:	Collaborator

Title:	A Study to evaluate patient samples with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Funding Source:	Funded by Stemline
Role:	Collaborator

Title:	A phase 1, open-label, dose escalation study of pf-04518600 as a single agent and in combination with pf-05082566 in patients with selected locally advanced or metastatic carcinomas
Funding Source:	Funded by Pfizer biopharmaceutical companies
Role:	Collaborator

Title:	Investigation of the biology of tumor angiogenesis, H-33324
Funding Source:	Funded by Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Collaborator

Title:	LGX818/MEK162 combination followed by a rational combination with targeted agents after progression
Funding Source:	Funded by Array BioPharma
Role:	Collaborator

Title:	Identification of Novel Molecular Therapeutic Targets in Merkel Cell Carcinoma by Genomic and Proteomic Profiling
Funding Source:	MD Anderson Institutional Grant For Early Career Faculty
Role:	PI

Title:	Analysis of Immunoprofile and Metabolic Signatures in Acral Melanoma
Funding Source:	The University of Texas MD Anderson Cancer Center/Division of Pathology and Lab Medicine
Role:	PI

Title:	A Comparative Analysis of SOX11, CK20, PAX5, and TTF-1 Expressions in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma: Anti-SOX11 as an Effective Discriminatory Immunohistochemical marker for Merkel Cell Carcinoma (Project with mentoring role)
Funding Source:	The University of Texas MD Anderson Cancer Center/Department of Pathology
Role:	PI

Title:	Understanding the Role of Epigenetic Alterations in TERT and Telomerase Activity in Merkel Cell Carcinoma: A Correlation Analysis of TERT Promoter Hypermethylation and TERT Protein Expression and Assessment of Their Prognostic Significance (Project with mentoring role)
Funding Source:	The University of Texas MD Anderson Cancer Center/Division of Pathology and Lab Medicine
Role:	PI

Title:	Molecular study of primary acral lentiginous melanoma from various ethnicities
Funding Source:	IRG
Role:	PI

Title:	Characterization of the Immune Landscape in Acral Lentiginous Melanoma and its Correlation with Patient Outcome and Response to Therapy in Four Different Ethnic Groups (Project with mentoring role)
Funding Source:	The University of Texas MD Anderson Cancer Center/Division of Pathology and Lab Medicine
Role:	PI

Title:	Genomic Analysis of Acral Lentiginous Melanoma in Comparison with UV-Associated Cutaneous Melanoma (Project with mentoring role)
Funding Source:	The University of Texas MD Anderson Cancer Center/Division of Pathology and Lab Medicine
Role:	PI

Title:	Expression of chemokines and other markers in cutaneous adnexal neoplasms (Project with mentoring role)
Funding Source:	Department of Pathology, The University of Texas MD Anderson Cancer Center
Role:	PI

Title:	Acral Lentiginous Melanoma: in the search for biomarkers for prognosis (Project with mentoring role)
Funding Source:	Department of Pathology, The University of Texas MD Anderson Cancer Center
Role:	PI

Title:	Epigenetic Analysis of Acral Lentiginous Melanoma in Comparison with UV-Associated Cutaneous Melanoma (Project with mentoring role)
Funding Source:	Division of Pathology and Lab medicine, The University of Texas MD Anderson Cancer Center
Role:	PI

CV information above last modified November 21, 2024

Phyu P Aung, M.D., Ph.D., F.CAP., F.ASCP

About Dr. Aung

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Invited Articles

Manuals, Teaching Aids, Other Teaching Publications

Other Articles

Book Chapters

Letters to the Editor

Grant & Contract Support

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

Phyu P Aung, M.D., Ph.D., F.CAP., F.ASCP

About Dr. Aung

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Invited Articles

Manuals, Teaching Aids, Other Teaching Publications

Other Articles

Book Chapters

Letters to the Editor

Grant & Contract Support

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Volunteer